Immunophage to Speak at ACCESS CHINA Partnering Forum

Oct 10th, 2023 (Shanghai) — We are glad to announce that Dr. Guohuang Fan, the CEO of Nanjing Immunophage Biotech, has been invited to present at ACCESS CHINA Partnering Forum on 9:45-10:00 am, October 17th, China time.

ACCESS CHINA Partnering Forum is the largest corporate access event between Asia and the western biopharma industry.

About the speaker

Guohuang Fan, Ph.D.

CEO of Nanjing Immunophage Biotech

Dr. Fan, President and CEO of Immunophage Biotech Co., Ltd., has an impressive background in biomedical research. In 2010, he Joined GSK R&D China as an Associate Director and was later appointed Adjunct Professor at Tongji University. In 2016, he became the Deputy Dean of the School of Translational Medicine, and Director of the Biomedical Research Center at Nanchang University, when he founded Immunophage Biotech Co., Ltd.

Dr. Fan is a renowned cancer biology and neurobiology expert, having published over 60 papers in peer-reviewed international journals and holding over 20 patents. His contributions have been recognized through various prestigious awards, including the National Natural Science Award (2002), the Chinese Medical Science Award (2001), and the Specialized Neuroscience Research Award from the NIH, USA (2007). He has also been honored as a scholar of “The Alexander Von Humboldt Fellowship” in Germany and a scholar of the “One-hundred Talent Program” by the Chinese Academy of Sciences.

Dr. Fan earned his M.D. and Ph.D. degrees from Shanghai Jiao Tong University School of Medicine in 1996. Following his doctoral studies, he underwent six years of postdoctoral training at the Chinese Academy of Sciences, the University of Wuerzburg, and Vanderbilt University. In 2002, he was appointed Research Assistant Professor at Vanderbilt University School of Medicine. Subsequently, in 2004, Dr. Fan became an Assistant Professor (tenure track) at Meharry Medical College, holding a secondary Assistant Professor position at Vanderbilt University School of Medicine. He was promoted to Associate Professor at Meharry Medical College in 2007 and later joined Virginia Commonwealth University School of Medicine as an Associate Professor in 2008.

About ACCESS CHINA Partnering Forum

ACCESS CHINA is the most effective deal-making platform for Western pharma and biotech leaders looking to enter or expand in the Chinese market. We organize a series of online and in-person partnering events since 2019 with the mission to facilitate the collaboration between Western and Eastern biotechs.

This Autumn event, as part of our quarterly series, will feature 40+ leading pharmaceutical companies delivering virtual roadshows to an audience of 500+ participants online. During the event, audience can have access to innovative biopharmas and healthcare products from worldwide.

Event Name: ACCESS CHINA Partnering Forum-2023 Autumn

Date & Time: Oct. 16th-17th, 2023

Location: Zoom Webinar

Content: Keynote Speech, Company Showcase

Participants: Pharma/Biotech senior management and BDs.

View more information at https://biotochina.org/

关于药通中国交易合作论坛2023

“ACCESS CHINA 药通中国交易合作论坛2023”于2023年10月16日至17日线上举办。自2020年始，药通中国论坛系列活动已成功举办14届，成为了海内外生物医药、医疗器械企业寻找合作的领先跨境交易路演平台。这里聚集了海内外医药界顶尖BD和管理人员，为项目交流搭建了高效的沟通渠道，为资产交易创造了宝贵的机会。

大会名称：药通中国交易合作论坛2023

大会日期：2023.10.16-17（线上）

大会内容：主题演讲、海内外优质项目路演

参会观众：海内外医药企业（药企及Biotech）高管及BD、基金高管

查看更多信息： https://biotochina.org/